Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cenicriviroc for COVID-19
NCT04500418Phase 2Terminated
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Aug 2020
- Primary completion
- Jul 2021
- Countries
- 1
01
Overview
A Phase 2 trial of cenicriviroc in coronavirus disease 2019 (COVID-19), sponsored by Charité – Universitätsmedizin Berlin. Started Aug 2020; status: terminated.
02
Drugs
cenicriviroc
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04500418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04500418.